Log in

NASDAQ:EPIXESSA Pharma Stock Price, Forecast & News

$5.22
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.10
Now: $5.22
$5.27
50-Day Range
$3.94
MA: $4.42
$5.25
52-Week Range
$1.41
Now: $5.22
$6.14
Volume9,414 shs
Average Volume24,082 shs
Market Capitalization$108.73 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Read More
ESSA Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.63 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EPIX
CUSIPN/A
Phone778-331-0962

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.93 per share

Profitability

Net Income$-10,440,000.00

Miscellaneous

Employees15
Market Cap$108.73 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

How has ESSA Pharma's stock been impacted by COVID-19 (Coronavirus)?

ESSA Pharma's stock was trading at $4.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EPIX shares have increased by 28.3% and is now trading at $5.22. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ESSA Pharma?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ESSA Pharma.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for ESSA Pharma.

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc (NASDAQ:EPIX) announced its earnings results on Thursday, May, 7th. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.23. View ESSA Pharma's earnings history.

What price target have analysts set for EPIX?

3 analysts have issued 1 year target prices for ESSA Pharma's stock. Their forecasts range from $8.00 to $9.00. On average, they anticipate ESSA Pharma's share price to reach $8.50 in the next year. This suggests a possible upside of 62.8% from the stock's current price. View analysts' price targets for ESSA Pharma.

Has ESSA Pharma been receiving favorable news coverage?

News coverage about EPIX stock has been trending very negative recently, according to InfoTrie. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ESSA Pharma earned a news impact score of -3.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutESSA Pharma.

Are investors shorting ESSA Pharma?

ESSA Pharma saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 26,800 shares, a decrease of 6.0% from the April 30th total of 28,500 shares. Based on an average trading volume of 32,800 shares, the short-interest ratio is presently 0.8 days. Approximately 0.2% of the shares of the company are sold short. View ESSA Pharma's Current Options Chain.

Who are some of ESSA Pharma's key competitors?

What other stocks do shareholders of ESSA Pharma own?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 69)
  • Mr. David S. Wood, Chief Financial Officer (Age 62)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 48)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 72)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 58)

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

Who are ESSA Pharma's major shareholders?

ESSA Pharma's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Soleus Capital Management L.P. (10.02%), RA Capital Management L.P. (4.62%), Janus Henderson Group PLC (0.96%) and Advisor Group Holdings Inc. (0.04%).

Which institutional investors are selling ESSA Pharma stock?

EPIX stock was sold by a variety of institutional investors in the last quarter, including RA Capital Management L.P..

Which institutional investors are buying ESSA Pharma stock?

EPIX stock was bought by a variety of institutional investors in the last quarter, including Soleus Capital Management L.P., Janus Henderson Group PLC, and Advisor Group Holdings Inc..

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $5.22.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $108.73 million. The company earns $-10,440,000.00 in net income (profit) each year or ($1.46) on an earnings per share basis. ESSA Pharma employs 15 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is www.essapharma.com.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.